{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:48:54Z","timestamp":1794606534851,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Malaysian Ministry of Higher Education","doi-asserted-by":"crossref","award":["UM.C\/HlR\/MOHE\/06"],"award-info":[{"award-number":["UM.C\/HlR\/MOHE\/06"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cancer Research Malaysia"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ygyno.2015.11.001","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T21:19:43Z","timestamp":1446671983000},"page":"318-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients"],"prefix":"10.1016","volume":"141","author":[{"given":"Hanis Nazihah","family":"Hasmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Nyin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Xiong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Jonathan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fa","family":"Nguyen-Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Choon Eng","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eswary","family":"Thirthagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahirah","family":"Ma'som","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Kiong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Southey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Ling","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-590X","authenticated-orcid":false,"given":"Soo-Hwang","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ygyno.2015.11.001_bb0005","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2015.11.001_bb0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2015.11.001_bb0015","series-title":"SEER Cancer Statistics Review, 1975\u20132010","author":"Howlader","year":"2013"},{"issue":"7","key":"10.1016\/j.ygyno.2015.11.001_bb0020","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-1029-3","article-title":"Pathology of ovarian cancers in BRCA1 and BRCA2 carriers","volume":"10","author":"Lakhani","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2015.11.001_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fonc.2014.00005","article-title":"BRCA and early events in the development of serous ovarian cancer","volume":"4","author":"George","year":"2014","journal-title":"Front Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2015.11.001_bb0030","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/annonc\/mdq628","article-title":"Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients","volume":"22","author":"Vencken","year":"2011","journal-title":"Ann. Oncol."},{"issue":"14","key":"10.1016\/j.ygyno.2015.11.001_bb0035","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.2011.1456","article-title":"Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer","volume":"306","author":"Yang","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ygyno.2015.11.001_bb0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.ygyno.2015.11.001_bb0045","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/JCO.2009.26.9589","article-title":"Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval","volume":"28","author":"Fong","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"9737","key":"10.1016\/j.ygyno.2015.11.001_bb0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(10)60893-8","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial","volume":"376","author":"Audeh","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ygyno.2015.11.001_bb0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.ejhg.5200652","article-title":"BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients","volume":"9","author":"Sarantaus","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.ygyno.2015.11.001_bb0060","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1158\/1078-0432.CCR-07-4806","article-title":"BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark","volume":"14","author":"Soegaard","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2015.11.001_bb0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejca.2003.09.016","article-title":"One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in southern Sweden","volume":"40","author":"Malander","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2015.11.001_bb0070","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.ygyno.2015.11.001_bb0075","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2015.11.001_bb0080","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/humu.20599","article-title":"Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer","volume":"28","author":"Ramus","year":"2007","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.ygyno.2015.11.001_bb0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1342 unselected patients with invasive ovarian cancer","volume":"121","author":"Zhang","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"21","key":"10.1016\/j.ygyno.2015.11.001_bb0090","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian ovarian cancer study group","volume":"30","author":"Alsop","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2015.11.001_bb0095","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1086\/302853","article-title":"BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer","volume":"66","author":"Moslehi","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ygyno.2015.11.001_bb0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM200107263450401","article-title":"Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation","volume":"345","author":"Modan","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2015.11.001_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/1098-1004(200007)16:1<88::AID-HUMU16>3.0.CO;2-G","article-title":"Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations","volume":"16","author":"Khoo","year":"2000","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.ygyno.2015.11.001_bb0110","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/342506","article-title":"Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan","volume":"71","author":"Liede","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2015.11.001_bb0115","series-title":"Malaysia National Cancer Registry Report","first-page":"2011","author":"Omar","year":"2007"},{"issue":"2","key":"10.1016\/j.ygyno.2015.11.001_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2144\/000114052","article-title":"A high-plex PCR approach for massively parallel sequencing","volume":"55","author":"Nguyen-Dumont","year":"2013","journal-title":"Biotechniques"},{"issue":"1","key":"10.1016\/j.ygyno.2015.11.001_bb0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2144\/000114247","article-title":"Abridged adapter primers increase the target scope of Hi-plex","volume":"58","author":"Nguyen-Dumont","year":"2015","journal-title":"Biotechniques"},{"issue":"1","key":"10.1016\/j.ygyno.2015.11.001_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1751-0473-9-3","article-title":"ROVER variant caller: read-pair overlap considerate variant-calling software applied to PCR-based massively parallel sequencing datasets","volume":"9","author":"Pope","year":"2014","journal-title":"Source Code Biol. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2015.11.001_bb0135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10549-015-3495-z","article-title":"Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2","volume":"152","author":"Park","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.ygyno.2015.11.001_bb0140","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1101\/gr.GR-1733RR","article-title":"Genetic evidence on the origins of Indian caste populations","volume":"11","author":"Bamshad","year":"2001","journal-title":"Genome Res."},{"issue":"7263","key":"10.1016\/j.ygyno.2015.11.001_bb0145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/461487a","article-title":"Human genetics: tracing India's invisible threads","volume":"461","author":"Chakravarti","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2015.11.001_bb0150","article-title":"Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries","author":"Kwong","year":"2015","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.ygyno.2015.11.001_bb0155","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/bcr2118","article-title":"Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer","volume":"10","author":"Thirthagiri","year":"2008","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2015.11.001_bb0160","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.ygyno.2015.11.001_bb0165","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian breast cancer study group","volume":"83","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"44","key":"10.1016\/j.ygyno.2015.11.001_bb0170","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2015.11.001_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/srep04026","article-title":"Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status","volume":"4","author":"Cunningham","year":"2014","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ygyno.2015.11.001_bb0180","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1634\/theoncologist.2012-0028","article-title":"BRCAness: finding the Achilles heel in ovarian cancer","volume":"17","author":"Rigakos","year":"2012","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.ygyno.2015.11.001_bb0185","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10549-010-1018-5","article-title":"Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families","volume":"124","author":"Kang","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ygyno.2015.11.001_bb0190","article-title":"Identification of a recurrent BRCA1 exon 21\u201322 genomic rearrangement in Malay breast cancer patients","author":"Hasmad","year":"2014","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ygyno.2015.11.001_bb0195","article-title":"Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation","author":"Kaufman","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"9737","key":"10.1016\/j.ygyno.2015.11.001_bb0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(10)60892-6","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial","volume":"376","author":"Tutt","year":"2010","journal-title":"Lancet"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T19:00:44Z","timestamp":1692126044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815301736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0090825815301736"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.001","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}